Literature DB >> 12676817

Contribution of sodium channel mutations to bradycardia and sinus node dysfunction in LQT3 families.

Marieke W Veldkamp1, Ronald Wilders, Antonius Baartscheer, Jan G Zegers, Connie R Bezzina, Arthur A M Wilde.   

Abstract

One variant of the long-QT syndrome (LQT3) is caused by mutations in the human cardiac sodium channel gene. In addition to the characteristic QT prolongation, LQT3 carriers regularly present with bradycardia and sinus pauses. Therefore, we studied the effect of the 1795insD Na+ channel mutation on sinoatrial (SA) pacemaking. The 1795insD channel was previously characterized by the presence of a persistent inward current (Ipst) at -20 mV and a negative shift in voltage dependence of inactivation. In the present study, we first additionally characterized Ipst over the complete voltage range of the SA node action potential (AP) by measuring whole-cell Na+ currents (INa) in HEK-293 cells expressing either wild-type or 1795insD channels. Ipst for 1795insD channels varied between 0.8+/-0.2% and 1.9+/-0.8% of peak INa. Activity of 1795insD channels during SA node pacemaking was confirmed by AP clamp experiments. Next, Ipst and the negative shift were implemented into SA node AP models. The -10-mV shift decreased sinus rate by decreasing diastolic depolarization rate, whereas Ipst decreased sinus rate by AP prolongation, despite a concomitant increase in diastolic depolarization rate. In combination, moderate Ipst (1% to 2%) and the shift reduced sinus rate by approximately 10%. An additional increase in Ipst could result in plateau oscillations and failure to repolarize completely. Thus, Na+ channel mutations displaying an Ipst or a negative shift in inactivation may account for the bradycardia seen in LQT3 patients, whereas SA node pauses or arrest may result from failure of SA node cells to repolarize under conditions of extra net inward current.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12676817     DOI: 10.1161/01.RES.0000069689.09869.A8

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  46 in total

1.  Sodium channel Scn1b null mice exhibit prolonged QT and RR intervals.

Authors:  Luis F Lopez-Santiago; Laurence S Meadows; Sara J Ernst; Chunling Chen; Jyoti Dhar Malhotra; Dyke P McEwen; Audrey Speelman; Jeffrey L Noebels; Sebastian K G Maier; Anatoli N Lopatin; Lori L Isom
Journal:  J Mol Cell Cardiol       Date:  2007-08-10       Impact factor: 5.000

Review 2.  The cardiac conduction system.

Authors:  David S Park; Glenn I Fishman
Journal:  Circulation       Date:  2011-03-01       Impact factor: 29.690

3.  Dual variation in SCN5A and CACNB2b underlies the development of cardiac conduction disease without Brugada syndrome.

Authors:  Dan Hu; Hector Barajas-Martinez; Vladislav V Nesterenko; Ryan Pfeiffer; Alejandra Guerchicoff; Jonathan M Cordeiro; Anne B Curtis; Guido D Pollevick; Yuesheng Wu; Elena Burashnikov; Charles Antzelevitch
Journal:  Pacing Clin Electrophysiol       Date:  2009-12-16       Impact factor: 1.976

4.  Computational analysis of the human sinus node action potential: model development and effects of mutations.

Authors:  Alan Fabbri; Matteo Fantini; Ronald Wilders; Stefano Severi
Journal:  J Physiol       Date:  2017-04-01       Impact factor: 5.182

5.  The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome.

Authors:  Naomasa Makita; Elijah Behr; Wataru Shimizu; Minoru Horie; Akihiko Sunami; Lia Crotti; Eric Schulze-Bahr; Shigetomo Fukuhara; Naoki Mochizuki; Takeru Makiyama; Hideki Itoh; Michael Christiansen; Pascal McKeown; Koji Miyamoto; Shiro Kamakura; Hiroyuki Tsutsui; Peter J Schwartz; Alfred L George; Dan M Roden
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

6.  Clinical Aspects of Type 3 Long-QT Syndrome: An International Multicenter Study.

Authors:  Arthur A M Wilde; Arthur J Moss; Elizabeth S Kaufman; Wataru Shimizu; Derick R Peterson; Jesaia Benhorin; Coeli Lopes; Jeffrey A Towbin; Carla Spazzolini; Lia Crotti; Wojciech Zareba; Ilan Goldenberg; Jørgen K Kanters; Jennifer L Robinson; Ming Qi; Nynke Hofman; David J Tester; Connie R Bezzina; Marielle Alders; Takeshi Aiba; Shiro Kamakura; Yoshihiro Miyamoto; Mark L Andrews; Scott McNitt; Bronislava Polonsky; Peter J Schwartz; Michael J Ackerman
Journal:  Circulation       Date:  2016-08-26       Impact factor: 29.690

7.  Autonomic modulation and antiarrhythmic therapy in a model of long QT syndrome type 3.

Authors:  Larissa Fabritz; Dierk Damke; Markus Emmerich; Susann G Kaufmann; Kathrin Theis; Andreas Blana; Lisa Fortmüller; Sandra Laakmann; Sven Hermann; Elena Aleynichenko; Johannes Steinfurt; Daniela Volkery; Burkhard Riemann; Uwe Kirchhefer; Michael R Franz; Günter Breithardt; Edward Carmeliet; Michael Schäfers; Sebastian K G Maier; Peter Carmeliet; Paulus Kirchhof
Journal:  Cardiovasc Res       Date:  2010-01-28       Impact factor: 10.787

8.  Multiple loss-of-function mechanisms contribute to SCN5A-related familial sick sinus syndrome.

Authors:  Junhong Gui; Tao Wang; Richard P O Jones; Dorothy Trump; Thomas Zimmer; Ming Lei
Journal:  PLoS One       Date:  2010-06-07       Impact factor: 3.240

Review 9.  Cardiac sodium channelopathies.

Authors:  Ahmad S Amin; Alaleh Asghari-Roodsari; Hanno L Tan
Journal:  Pflugers Arch       Date:  2009-11-29       Impact factor: 3.657

10.  The cardiac sodium channel displays differential distribution in the conduction system and transmural heterogeneity in the murine ventricular myocardium.

Authors:  C A Remme; A O Verkerk; W M H Hoogaars; W T J Aanhaanen; B P Scicluna; C Annink; M J B van den Hoff; A A M Wilde; T A B van Veen; M W Veldkamp; J M T de Bakker; V M Christoffels; C R Bezzina
Journal:  Basic Res Cardiol       Date:  2009-03-03       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.